News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Protox Therapeutics Inc. Announces 2007 Annual and Special Meeting
June 13, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VANCOUVER, June 13 /CNW/ - Protox(TM) Therapeutics Inc. (TSX-V:PRX) announced today that Dr. Fahar Merchant, President and CEO of Protox, will host the Company's 2007 Annual and Special Meeting on Friday, June 15 to discuss fiscal 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoffs
TScan cuts 75% of workforce while shifting focus to solid tumor program
September 3, 2026
·
2 min read
·
Angela Gabriel
Funding
US to grant up to $125M for personalized RNA manufacturing innovation
September 3, 2026
·
2 min read
·
Michael Gibney
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
·
1 min read
·
Tristan Manalac
FDA
Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
September 2, 2026
·
2 min read
·
Jef Akst
